| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.29B | — | +1.5% |
| Cost of Revenue | $350.6M | — | -2.2% |
| Gross Profit | $937.5M | — | +3.0% |
| R&D Expense | $169.1M | — | -11.3% |
| SG&A Expense | $105.8M | — | -0.9% |
| Operating Income | $269.9M | — | +30.9% |
| Pre-tax Income | $185.9M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.09B | -6.0% | +8.7% |
| Accounts Receivable | $591.0M | -10.4% | -0.3% |
| Current Assets | $2.14B | -2.9% | +7.9% |
| Total Assets | $13.48B | -2.2% | -2.2% |
| Current Liabilities | $2.46B | -10.4% | -1.5% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $147.8M | — | +289.9% |
| Investing Cash Flow | -$45.0M | — | -23.6% |
| Financing Cash Flow | -$176.4M | — | +4.8% |
| +115.4% |
| Income Tax | $39.2M | — | +1981.7% |
| Net Income | $146.6M | — | +73.8% |
| EPS (Basic) | $0.58 | — | +81.2% |
| EPS (Diluted) | $0.58 | — | +81.2% |
| $6.37B |
| -0.1% |
| -0.2% |
| Stockholders' Equity | $3.95B | +0.6% | -4.5% |